Stem cells in gastroenterology: prospects and problems
Abstract
The aim of review. To generalize cumulative data on the role of stem cells (SC) in treatment of gastroenterological diseases.
Original positions. Cell-based treatment is rather new and, probably, promising trend in treatment of many severe diseases in which traditional methods fail to achieve due results. In therapeutic aspect of gastrointestinal and liver diseases inflammatory bowel diseases, colorectal cancer and decompensated liver cirrhosis seem to be most perspective at the present stage. At the same time clinical application of SC is associated to array of serious problems: immune rejection and «graft-versus-host» response, neoplastic transformation as well as ethical and religious restrictions.
Conclusion. Application SC in clinical gastroenterology is premature today. Their efficacy and safety requires confirmation in multicenter randomized trials.
About the Authors
A. O. Buyeverov
Государственное образовательное учреждение высшего профессионального образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минзравсоцразвития РФ
Russian Federation
Russian Federation
V. T. Ivashkin
Государственное образовательное учреждение высшего профессионального образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минзравсоцразвития РФ
Russian Federation
Russian Federation
References
1. Лазебник Л.Б., Князев О.В., Коноплянников А.Г. и др. Аллогенные мезенхимальные стромальные клетки в лечении больных язвенным колитом: два года наблюдения // Клин. эксперимент. гастроэнтерол. – 2010. – № 11. – С. 3–15.
2. Яргин С.В. Стволовые клетки и клеточная терапия: на подступах к научному подходу // Цитология. – 2010. – Т. 52, № 11. – С. 918–920.
3. Aglietta M., Barkholt L., Schianca F.C. et al. Reducedintensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience // Biol. Blood Marrow Transplant. – 2009. – Vol. 15. – P. 326–335.
4. Almeida-Porada G., Zanjani E.D., Porada C.D. Bone marrow stem cells and liver regeneration // Exp. Hematol. – 2010. – Vol. 38. – P. 574–580.
5. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization // Int. J. Biochem. Cell Biol. – 2004. – Vol. 36. – P. 568–584.
6. Blau H.M, Brazelton T.R, Weimann J.M. The evolving concept of a stem cell: entity or function? // Cell. – 2001. – Vol. 105. – P. 829–841.
7. Boquest A.C., Noer A., Collas P. Epigenetic programming of mesenchymal stem cells from human adipose tissue // Stem Cell Rev. – 2006. – Vol. 2. – P. 319–329.
8. Bryant D.H. Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? // Eur. Respir. J. – 2005. – Vol. 25. – P. 402–404.
9. Burt R.K., Traynor A., Oyama Y., Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease // Blood. – 2003. – Vol. 101. – P. 2064–2066.
10. Carnevale-Schianca F., Cignetti A., Capaldi A. et al. Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD // Blood. – 2006. – Vol. 107. – P. 3795–3803.
11. Cassinotti A., Annaloro C., Ardizzone S. et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn’s disease // Gut. – 2008. – Vol. 57. – P. 211–217.
12. Deasy B.M., Li Y., Huard J. Tissue engineering with muscle-derived stem cells // Curr. Opin. Biotechnol. – 2004. – Vol. 15. – P. 419–423.
13. Ditchkowski M., Einsele H., Schwerdtfeger R. et al.
14. Improvement of inflammatory bowel disease after allogenic stem-cell transplantation // Transplantation. – 2003. – Vol. 75. – P. 1745–1747.
15. Dryden G.W. Overview of stem cell therapy for Crohn disease // Expert. Opin. Biol. Ther. – 2009. – Vol. 9. – P. 841–847.
16. Esch J.S., Knoefel W.T., Klein M. et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration // Stem Cells. – 2005. – Vol. 23. – P. 463–470.
17. Fabrizi E., di Martino S., Pelacchi F., Ricci-Vitiani L. Therapeutic implications of colon cancer stem cells // World J. Gastroenterol. – 2010. – Vol. 21. – P. 3871–3877.
18. Fang T.C., Alison M.R., Wright N.A., Poulsom R. Adult stem cell plasticity: will engineered tissues be rejected? // Int. J. Exp. Pathol. – 2004. – Vol. 85. – P. 115–124.
19. Filip S., Mokry J., Horacek J., English D. Stem cells and the phenomena of plasticity and diversity: a limiting property of carcinogenesis // Stem Cells Dev. – 2008. – Vol. 17. – P. 1031–1038.
20. Fortier L.A. Stem cells: classifications, controversies, and clinical applications // Vet. Surg. – 2005. – Vol. 34. – P. 415–423.
21. Gordon M.Y., Levicar N., Pai M. et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor // Stem Cells. – 2006. – Vol. 24. – P. 822–1830.
22. Hashino S., Kobayashi S., Takahata M. et al. Graftversus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer // Int. J. Clin. Oncol. – 2008. – Vol. 13. – P. 176–180.
23. Lee S.H., Yoo K.H., Sung K.W. et al. Hepatic venoocclusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome // Bone Marrow Transplant. – 2010. – Vol. 45. – P. 1287–1293.
24. Lindvall O., Kokaia Z. Stem cells for the treatment of neurological disorders // Nature. – 2006. – Vol. 441. – P. 1094–1096.
25. Lodi D., Iannitti T., Palmieri B. Stem cells in clinical practice: applications and warnings // J. Exp. Clin. Cancer Res. – 2011. – Vol. 30. – P. 9–20.
26. Lyra A.C., Soares M.B., da Silva L.F. et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease // World J. Gastroenterol. – 2007. – Vol. 13, N 7. – P. 1067–1073.
27. Lyra A.C., Soares M.B., da Silva L.F. et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study // Eur. J. Gastroenterol. Hepatol. – 2010. – Vol. 22, N 1. – P. 33–42.
28. Meirelles Lda S., Nardi N.B. Methodology, biology and clinical applications of mesenchymal stem cells // Front Biosci. – 2009. – Vol. 14. – P. 4281–4298.
29. Mohamadnejad M., Namiri M., Bagheri M. et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis // World J. Gastroenterol. – 2007. – Vol. 13. – P. 3359–3363.
30. O’Donoghue K., Fisk N.M. Fetal stem cells // Best Pract. Res. Clin. Obstet. Gynaecol. – 2004. –Vol. 18. – P. 853–875.
31. Odorico J.S., Kaufman D.S., Thomson J.A. Multilineage differentiation from human embryonic stem cell lines // Stem Cells. – 2001. – Vol. 19. – P. 193–204.
32. Oyama Y., Craig R.M., Traynor A.E. et al. Autologous hematopoietic stem cells transplantation in patients with refractory Crohn’s disease // Gastroenterology. – 2005. – Vol. 128. – P. 552–563.
33. Pai M., Zacharoulis D., Milicevic M.N. et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis // Am. J. Gastroenterol. – 2008. – Vol. 103. – P. 1952–1958.
34. Pepper M.S. Cell-based therapy – navigating troubled waters // S. Afr. Med. J. – 2010. – Vol. 100. –P. 286–288.
35. Pittenger M.F., Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics // Circ. Res. – 2004. – Vol. 95. – P. 9–20.
36. Reddy P., Arora M., Guimond M., Mackall C.L. GVHD: a continuing barrier to the safety of allogeneic transplantation // Biol. Blood Marrow Transplant. – 2009. – Vol. 15 (suppl. 1). – P. 162–168.
37. Rosler E.S., Fisk G.J., Ares X. et al. Long-term culture of human embryonic stem cells in feeder-free conditions // Dev. Dyn. – 2004. – Vol. 229. – P. 259–274.
38. Ruetze M., Gallinat S., Lim I.J. et al. Common features of umbilical cord epithelial cells and epidermal keratinocytes // J. Dermatol. Sci. – 2008. – Vol. 50. – P. 227–231.
39. Singh U.P., Singh N.P., Singh B. et al. Stem cells as potential therapeutic targets for inflammatory bowel disease // Front Biosci. – 2010. – Vol. 1. – P. 993–1008.
40. Tan S.C., Pan W.X., Ma G. et al. Viscoelastic behaviour of human mesenchymal stem cells // BMC Cell Biol. – 2008. – Vol. 9. – P. 40.
41. Terai S., Ishikawa T., Omori K. et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy // Stem Cells. – 2006. – Vol. 24. – P. 2292–2298.
42. Todaro M., Alea M.P., Di Stefano A.B. et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 // Cell Stem Cell. – 2007. – Vol. 1. – P. 389–402.
43. Vicente-Duenas C., Gutierrez de Diego J., Rodriguez F.D. et al. The role of cellular plasticity in cancer development. – Curr. Med. Chem. – 2009. – Vol. 16. – P. 3676–3685.
44. Wright W.E., Shay J.W. Historical claims and current interpretations of replicative aging // Nat. Biotechnol. – 2002. – Vol. 20. – P. 682–688.
45. Yamashita J.K. ES and iPS cell research for cardiovascular regeneration // Exp. Cell Res. – 2010. – Vol. 316. – P. 2555–2559.
46. Zarzeczny A., Caulfield T. Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo // Stem Cell Rev. – 2009. – Vol. 5. – P. 96–101.
47. Zuk P.A., Zhu M., Mizuno H. et al. Multilineage cells from human adipose tissue: implications for cell-based therapies // Tissue Eng. – 2001. – Vol. 7. – P. 211– 228.
Review
For citations:
Buyeverov A.O., Ivashkin V.T. Stem cells in gastroenterology: prospects and problems. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2011;21(6):4-11. (In Russ.)
Views:
65
Email this article 
